Showing results (151-160 of 330) with videos related to

Sort By:
Pageof 33
Journal of Gastroenterology|June 20, 2020
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patientsLilian Yan Liang, Vincent Wai-Sun Wong, Hidenori Toyoda, et al.
British Journal of Cancer|January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasionImam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Scientific Reports|February 6, 2025
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver diseaseYudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 26, 2022
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosisMinako Yuri, Takashi Nishimura, Toshifumi Tada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological responseToshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Molecular and Clinical Oncology|April 18, 2017
Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablationAtsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 8, 2017
Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing DialysisHidenori Toyoda, Atsushi Hiraoka, Toshifumi Tada, et al.
Journal of Gastroenterology and Hepatology|December 10, 2015
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinomaAtsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, et al.
Oncology|March 30, 2025
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab TherapyKhanh Van Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
Pageof 33